on April 20, 2006
Published online before print April 20, 2006, doi: 10.1161/01.ATV.0000223143.88128.19
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 28, 2005
Accepted on April 7, 2006
Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice
Peter J. Kuhlencordt *;
From Medizinische Klinik I (P.J.K., S.H., J.S., S.R., K.H., J.W., G.E.), Cardiovascular Center and Department of Pathology (A.M.), University Wuerzburg, Germany; Division of Cardiology (P.L.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Mass.
* To whom correspondence should be addressed. E-mail: kuhlencord_p{at}klink.uni-wuerzburg.de.
Objective--All 3 isoforms of the nitric oxide synthase (NOS) are expressed in atherosclerotic lesions. To test whether neuronal NOS (nNOS) deficiency affects atherosclerosis, we studied apoE/nNOS
double knockout (DKO) and apolipoprotein E (apoE) knockout (KO) control mice.
Methods and Results--Lesion area was significantly increased in male DKO (66%) mice after 14 weeks and in female DKO animals (31%) after 24 weeks of "western" diet. Moreover, mean arterial blood pressure was significantly reduced in female DKO animals. Immunohistochemistry revealed nNOS expression in the neointima of KO mice. In DKO animals, residual nNOS staining was caused by the presence of nNOS splice variants. Whereas nNOS was present in vessels of KO and absent in DKO animals, nNOS
was expressed in KO and DKO mice.
Conclusion--nNOS protects against atherosclerosis as nNOS deletion leads to an increase in plaque formation in apoE/nNOS DKO mice. Female DKO mice showed a significant reduction in mean arterial blood pressure. Additionally, we found expression of nNOS splice variants in vessels of apoE KO mice. Our data highlights nNOS overexpression as a potential therapeutic strategy and naturally occurring splice variants that lack exon 2 of the nNOS gene as a potential risk factor for vascular disease.
Related Article:
- Beneficial Effects of Neuronal Nitric Oxide Synthase in Atherosclerosis
- Charles J. Lowenstein
Arterioscler. Thromb. Vasc. Biol. 2006 26: 1417-1418.[Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling Cardiovasc Res, January 15, 2008; 77(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W.T. Liu and P. L. Huang Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice Cardiovasc Res, January 1, 2008; 77(1): 19 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nakata, M. Tsutsui, H. Shimokawa, T. Yamashita, A. Tanimoto, H. Tasaki, K. Ozumi, K. Sabanai, T. Morishita, O. Suda, et al. Statin Treatment Upregulates Vascular Neuronal Nitric Oxide Synthase Through Akt/NF-{kappa}B Pathway Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lowenstein Beneficial effects of neuronal nitric oxide synthase in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1417 - 1418. [Full Text] [PDF]
|
|